Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Seattle_Genetics> ?p ?o }
- Seattle_Genetics abstract "Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs, a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. Antibody-drug Conjugates are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.The companys' flagship product Adcetris (Brentuximab vedotin) is commercially available for two indications in 50 countries, including the U.S., Canada, Japan and members of the European Union. The approval of Brentuximab vedotin makes it the first in a new class of ADCs.To expand on the clinical opportunities of brentuximab vedotin, Seattle Genetics is conducting a broad clinical development program to evaluate its therapeutic potential in earlier lines of its approved indications as well as in a range of other lymphoma and non-lymphoma settings. The company is jointly developing brentuximab vedotin in collaboration with Takeda Pharmaceutical Company. Under the terms of the collaboration, Seattle Genetics has full commercialization rights to brentuximab vedotin in the United States and Canada. Takeda has exclusive rights to commercialize the product candidate in all other countries.In addition to brentuximab vedotin, Seattle Genetics' product pipeline includes SGN-CD19A, an Antibody-drug conjugate (ADC) targeting CD19, SGN-CD33A, an ADC targeting CD33, SGN-LIV1A, an ADC targeting LIV-1, SGN-CD70A, an ADC targeting CD70, as well as ASG-22ME and ASG-15ME, ADCs that we are co-developing with Agensys (an affiliate of Astellas), an early-stage privately held biotechnology company based in Los Angeles, focusing on the development of fully human monoclonal antibodies to treat solid tumor cancers in a variety of cancer targets.".
- Seattle_Genetics foundingDate "1997-07-15".
- Seattle_Genetics foundingYear "1997".
- Seattle_Genetics industry Biotechnology.
- Seattle_Genetics industry Pharmaceutical_drug.
- Seattle_Genetics keyPerson Chairman.
- Seattle_Genetics keyPerson Chief_Medical_Officer.
- Seattle_Genetics keyPerson Chief_executive_officer.
- Seattle_Genetics keyPerson Chief_financial_officer.
- Seattle_Genetics keyPerson Chief_operating_officer.
- Seattle_Genetics keyPerson Vice_president.
- Seattle_Genetics location Bothell,_Washington.
- Seattle_Genetics location United_States.
- Seattle_Genetics location Washington_(state).
- Seattle_Genetics numberOfEmployees "650".
- Seattle_Genetics product Antibody-drug_conjugate.
- Seattle_Genetics product Brentuximab_vedotin.
- Seattle_Genetics type Public_company.
- Seattle_Genetics wikiPageExternalLink www.seattlegenetics.com.
- Seattle_Genetics wikiPageID "41426599".
- Seattle_Genetics wikiPageLength "26258".
- Seattle_Genetics wikiPageOutDegree "100".
- Seattle_Genetics wikiPageRevisionID "702861293".
- Seattle_Genetics wikiPageWikiLink ASG-22ME.
- Seattle_Genetics wikiPageWikiLink ASG-5ME.
- Seattle_Genetics wikiPageWikiLink AbbVie_Inc..
- Seattle_Genetics wikiPageWikiLink Abbott_Laboratories.
- Seattle_Genetics wikiPageWikiLink Acute_myeloid_leukemia.
- Seattle_Genetics wikiPageWikiLink Anaplastic_large-cell_lymphoma.
- Seattle_Genetics wikiPageWikiLink Antibody-drug_conjugate.
- Seattle_Genetics wikiPageWikiLink Auristatin.
- Seattle_Genetics wikiPageWikiLink B-cell_lymphoma.
- Seattle_Genetics wikiPageWikiLink Bayer.
- Seattle_Genetics wikiPageWikiLink Biotechnology.
- Seattle_Genetics wikiPageWikiLink Bothell,_Washington.
- Seattle_Genetics wikiPageWikiLink Breast_cancer.
- Seattle_Genetics wikiPageWikiLink Brentuximab_vedotin.
- Seattle_Genetics wikiPageWikiLink CD30.
- Seattle_Genetics wikiPageWikiLink Category:Pharmaceutical_companies_of_the_United_States.
- Seattle_Genetics wikiPageWikiLink Chairman.
- Seattle_Genetics wikiPageWikiLink Chief_Medical_Officer.
- Seattle_Genetics wikiPageWikiLink Chief_executive_officer.
- Seattle_Genetics wikiPageWikiLink Chief_financial_officer.
- Seattle_Genetics wikiPageWikiLink Chief_operating_officer.
- Seattle_Genetics wikiPageWikiLink Dacetuzumab.
- Seattle_Genetics wikiPageWikiLink Everolimus.
- Seattle_Genetics wikiPageWikiLink File:Seattle_Genetics_logo.gif.
- Seattle_Genetics wikiPageWikiLink Genentech.
- Seattle_Genetics wikiPageWikiLink Genmab.
- Seattle_Genetics wikiPageWikiLink GlaxoSmithKline.
- Seattle_Genetics wikiPageWikiLink Health_Canada.
- Seattle_Genetics wikiPageWikiLink Hodgkins_lymphoma.
- Seattle_Genetics wikiPageWikiLink MedImmune.
- Seattle_Genetics wikiPageWikiLink Millennium_Pharmaceuticals.
- Seattle_Genetics wikiPageWikiLink Monoclonal_antibody.
- Seattle_Genetics wikiPageWikiLink Monomethyl_auristatin_E.
- Seattle_Genetics wikiPageWikiLink Monomethyl_auristatin_F.
- Seattle_Genetics wikiPageWikiLink Mycosis_fungoides.
- Seattle_Genetics wikiPageWikiLink Non-Hodgkin_lymphoma.
- Seattle_Genetics wikiPageWikiLink Orphan_drug.
- Seattle_Genetics wikiPageWikiLink Pancreatic_cancer.
- Seattle_Genetics wikiPageWikiLink Pfizer.
- Seattle_Genetics wikiPageWikiLink Pharmaceutical_drug.
- Seattle_Genetics wikiPageWikiLink Public_company.
- Seattle_Genetics wikiPageWikiLink Pyrrolobenzodiazepine.
- Seattle_Genetics wikiPageWikiLink Renal_cell_carcinoma.
- Seattle_Genetics wikiPageWikiLink SGN-CD19A.
- Seattle_Genetics wikiPageWikiLink SGN-CD70A.
- Seattle_Genetics wikiPageWikiLink SLC44A4.
- Seattle_Genetics wikiPageWikiLink Seattle.
- Seattle_Genetics wikiPageWikiLink T_cell.
- Seattle_Genetics wikiPageWikiLink Takeda_Pharmaceutical_Company.
- Seattle_Genetics wikiPageWikiLink Tumors_of_the_hematopoietic_and_lymphoid_tissues.
- Seattle_Genetics wikiPageWikiLink United_States.
- Seattle_Genetics wikiPageWikiLink Unum_Therapeutics.
- Seattle_Genetics wikiPageWikiLink Vadastuximab_talirine_(SGN-CD33A).
- Seattle_Genetics wikiPageWikiLink Vice_president.
- Seattle_Genetics wikiPageWikiLink Vorsetuzumab_mafodotin.
- Seattle_Genetics wikiPageWikiLink Washington_(state).
- Seattle_Genetics wikiPageWikiLinkText "Seattle Genetics".
- Seattle_Genetics foundation "--07-15".
- Seattle_Genetics homepage www.seattlegenetics.com.
- Seattle_Genetics industry Biotechnology.
- Seattle_Genetics industry Pharmaceutical_drug.
- Seattle_Genetics keyPeople "( Sales)".
- Seattle_Genetics keyPeople "( Technical Operations and Process Sciences)".
- Seattle_Genetics keyPeople "(Lead Independent Director)".
- Seattle_Genetics keyPeople "(Senior Director Corporate Communications)".
- Seattle_Genetics keyPeople "Charles Romp".
- Seattle_Genetics keyPeople "Clay B. Siegall Ph.D".
- Seattle_Genetics keyPeople "Felix Baker".
- Seattle_Genetics keyPeople "Pinkston Peggy".
- Seattle_Genetics keyPeople "Todd E. Simpson".
- Seattle_Genetics keyPeople "Vaughn Himes".
- Seattle_Genetics location Bothell,_Washington.
- Seattle_Genetics location United_States.
- Seattle_Genetics location Washington_(state).
- Seattle_Genetics logo "225".
- Seattle_Genetics name "Seattle Genetics".
- Seattle_Genetics products "Brentuximab vedotin and other Antibody-drug conjugates".